Felis ISSN 2398-2950
Pimobendan
Contributor(s): Yolande Bishop, Sonja Fonfara
Introduction
Name
Class of drug
Description
Chemical name
- 4,5-Dihydro-6-[2-(p-methyoxyphenyl)-5-benzimidazolyl]-5-methyl-3(2H-pyridazinone).
Molecular formula
Molecular weight
Storage requirements
- Do not store above 25° C.
- Store in a dry place.
Uses
This article is available in full to registered subscribers
Sign up now to purchase a 30 day trial, or
Login
Indications
- No evidence present so far, abstracts presented for use in cats:
- Off license use in cats with endstage myocardial disease with systolic and diastolic dysfunction and refractory congestive heart failure Heart: congestive heart failure .
Administration
This article is available in full to registered subscribers
Sign up now to purchase a 30 day trial, or
Login
Pharmacokinetics
This article is available in full to registered subscribers
Sign up now to purchase a 30 day trial, or
Login
Precautions
This article is available in full to registered subscribers
Sign up now to purchase a 30 day trial, or
Login
Interactions
with other drugs
- Verapamil → reduced action of pimobendan.
- Propranolol → reduced action of pimobendan.
Adverse Reactions
This article is available in full to registered subscribers
Sign up now to purchase a 30 day trial, or
Login
Further Reading
Publications
Refereed papers
Other sources of information
- McGregor (2010)ACVIM abstract 2010:Use of Pimobendan in 161 cats.
- Gordon S (2010)ACVIM abstract 2010: Use of Pimobendan in 28 cats with cardiac disease.
- The Veterinary Formulary.5th edn (2001) Bishop, Y (Ed.) British Veterinary Association and Pharmaceutical Press.